Hims says it will stop selling GLP-1 pill, after legal pressure from US
The telehealth company Hims & Hers said it will no longer sell a compounded version of Novo Nordisk's Wegovy pill, just days after announcing the new product.
The move comes after Novo, which launched its ...
⚠️ 风险分析 中
摘要：美国远程医疗公司Hims因法律压力，宣布停止销售诺和诺德GLP-1药物仿制版。
影响：此事件凸显了在海外市场销售仿制或复合药物面临的知识产权诉讼风险，可能影响中国类似出海企业的产品策略。
建议：出海企业需严格审查目标市场知识产权法规，避免侵权风险，并建立合规的产品上市前审查机制。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.